SIN Retroviral Vectors Expressing COL7A1 Under Human Promoters for Ex Vivo Gene Therapy of Recessive Dystrophic Epidermolysis Bullosa
Open Access
- 1 August 2010
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (8), 1509-1518
- https://doi.org/10.1038/mt.2010.91
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Transcriptional Enhancers Induce Insertional Gene Deregulation Independently From the Vector Type and DesignMolecular Therapy, 2009
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyJCI Insight, 2009
- Stem Cell Marking With Promotor-deprived Self-inactivating Retroviral Vectors Does Not Lead to Induced Clonal ImbalanceMolecular Therapy, 2009
- Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypesJournal of Medical Genetics, 2006
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cellsNature Medicine, 2006
- Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site SelectionPLoS Pathogens, 2006
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLoS Biology, 2004
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Location of stem cells of human hair follicles by clonal analysisCell, 1994
- Three clonal types of keratinocyte with different capacities for multiplication.Proceedings of the National Academy of Sciences of the United States of America, 1987